Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials

P.W. Owens, M. Saeed, N. McCawley, P. Loughlin, D.E. Kearney, J.P. Burke, D.A. McNamara, S.M. Sahebally
{"title":"Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials","authors":"P.W. Owens,&nbsp;M. Saeed,&nbsp;N. McCawley,&nbsp;P. Loughlin,&nbsp;D.E. Kearney,&nbsp;J.P. Burke,&nbsp;D.A. McNamara,&nbsp;S.M. Sahebally","doi":"10.1016/j.surge.2024.03.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Long-course neoadjuvant chemoradiotherapy (NCRT), followed by surgery after an interval of 6–8 weeks, represents standard of care for patients with locally advanced rectal cancer (LARC). Increasing this interval may improve rates of complete pathological response (pCR) and tumour downstaging. We performed a meta-analysis comparing standard (SI, within 8 weeks) versus longer (LI, after 8 weeks) interval from NCRT to surgery.</p></div><div><h3>Methods</h3><p>PubMed, Embase, and Cochrane databases were searched up to 31 August 2022. Randomized controlled trials (RCTs) comparing SI with LI after NCRT for LARC were included. The primary endpoint was pCR rate. Secondary endpoints included rates of R0 resection, circumferential resection margin positivity (+CRM), TME completeness, lymph node yield (LNY), operative duration, tumour downstaging (TD), sphincter preservation, mortality, postoperative complications, surgical site infection (SSI) and anastomotic leak (AL). Random effects models were used to calculate pooled effect size estimates.</p></div><div><h3>Results</h3><p>Four RCTs encompassing 867 patients were included. There were 539 males (62.1%). LI was associated with a higher pCR rate (OR 0.61, 95%CI ​= ​0.39–0.95, p ​= ​0.03), and more TD (OR 0.60, 95%CI ​= ​0.37–0.97, p ​= ​0.04) compared to SI. However, there was no difference in rates of R0 resection (p ​= ​0.87), +CRM (p ​= ​0.66), sphincter preservation (p ​= ​0.26), incomplete TME (p ​= ​0.49), LNY (p ​= ​0.55), SSI (p ​= ​0.33), AL (p ​= ​0.20), operative duration (p ​= ​0.07), mortality (p ​= ​0.89) or any surgical complication (p ​= ​0.91).</p></div><div><h3>Conclusions</h3><p>A LI to surgery after NCRT for LARC increases pCR and TD rates. Local recurrence or survival were not assessed due to unavailable data. We recommend deferring TME until after an interval of 8 weeks following completion of NCRT.</p></div>","PeriodicalId":49463,"journal":{"name":"Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","volume":"22 3","pages":"Pages 166-173"},"PeriodicalIF":2.3000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1479666X24000283","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Long-course neoadjuvant chemoradiotherapy (NCRT), followed by surgery after an interval of 6–8 weeks, represents standard of care for patients with locally advanced rectal cancer (LARC). Increasing this interval may improve rates of complete pathological response (pCR) and tumour downstaging. We performed a meta-analysis comparing standard (SI, within 8 weeks) versus longer (LI, after 8 weeks) interval from NCRT to surgery.

Methods

PubMed, Embase, and Cochrane databases were searched up to 31 August 2022. Randomized controlled trials (RCTs) comparing SI with LI after NCRT for LARC were included. The primary endpoint was pCR rate. Secondary endpoints included rates of R0 resection, circumferential resection margin positivity (+CRM), TME completeness, lymph node yield (LNY), operative duration, tumour downstaging (TD), sphincter preservation, mortality, postoperative complications, surgical site infection (SSI) and anastomotic leak (AL). Random effects models were used to calculate pooled effect size estimates.

Results

Four RCTs encompassing 867 patients were included. There were 539 males (62.1%). LI was associated with a higher pCR rate (OR 0.61, 95%CI ​= ​0.39–0.95, p ​= ​0.03), and more TD (OR 0.60, 95%CI ​= ​0.37–0.97, p ​= ​0.04) compared to SI. However, there was no difference in rates of R0 resection (p ​= ​0.87), +CRM (p ​= ​0.66), sphincter preservation (p ​= ​0.26), incomplete TME (p ​= ​0.49), LNY (p ​= ​0.55), SSI (p ​= ​0.33), AL (p ​= ​0.20), operative duration (p ​= ​0.07), mortality (p ​= ​0.89) or any surgical complication (p ​= ​0.91).

Conclusions

A LI to surgery after NCRT for LARC increases pCR and TD rates. Local recurrence or survival were not assessed due to unavailable data. We recommend deferring TME until after an interval of 8 weeks following completion of NCRT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
局部晚期直肠癌新辅助化疗后延长手术时间间隔:随机对照试验荟萃分析。
背景:长程新辅助化放疗(NCRT)是局部晚期直肠癌(LARC)患者的标准治疗方法,间隔 6-8 周后进行手术。延长这一间隔可提高完全病理反应(pCR)率和肿瘤降期率。我们进行了一项荟萃分析,比较了从 NCRT 到手术的标准间隔(SI,8 周内)与更长间隔(LI,8 周后):方法:检索了截至 2022 年 8 月 31 日的 PubMed、Embase 和 Cochrane 数据库。方法:检索了截至 2022 年 8 月 31 日的 PubM、Embed 和 Cochrane 数据库,纳入了 LARC NCRT 后比较 SI 与 LI 的随机对照试验(RCT)。主要终点是 pCR 率。次要终点包括R0切除率、周切缘阳性率(+CRM)、TME完整性、淋巴结率(LNY)、手术持续时间、肿瘤降期(TD)、括约肌保留率、死亡率、术后并发症、手术部位感染(SSI)和吻合口漏(AL)。随机效应模型用于计算汇集效应大小估计值:结果:共纳入了四项研究,涉及 867 名患者。其中有 539 名男性(62.1%)。与SI相比,LI与更高的pCR率(OR 0.61,95%CI = 0.39-0.95,p = 0.03)和更多的TD(OR 0.60,95%CI = 0.37-0.97,p = 0.04)相关。然而,R0切除率(p = 0.87)、+CRM(p = 0.66)、括约肌保留率(p = 0.26)、不完全TME(p = 0.49)、LNY(p = 0.55)、SSI(p = 0.33)、AL(p = 0.20)、手术时间(p = 0.07)、死亡率(p = 0.89)或任何手术并发症(p = 0.91)均无差异:结论:LARC NCRT 后进行手术可提高 pCR 和 TD 率。结论:LARC NCRT 后进行手术可提高 pCR 和 TD 率,但由于数据不详,未对局部复发率或生存率进行评估。我们建议将TME推迟到NCRT结束后8周。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
158
审稿时长
6-12 weeks
期刊介绍: Since its establishment in 2003, The Surgeon has established itself as one of the leading multidisciplinary surgical titles, both in print and online. The Surgeon is published for the worldwide surgical and dental communities. The goal of the Journal is to achieve wider national and international recognition, through a commitment to excellence in original research. In addition, both Colleges see the Journal as an important educational service, and consequently there is a particular focus on post-graduate development. Much of our educational role will continue to be achieved through publishing expanded review articles by leaders in their field. Articles in related areas to surgery and dentistry, such as healthcare management and education, are also welcomed. We aim to educate, entertain, give insight into new surgical techniques and technology, and provide a forum for debate and discussion.
期刊最新文献
Enhancements in artificial intelligence for medical examinations: A leap from ChatGPT 3.5 to ChatGPT 4.0 in the FRCS trauma & orthopaedics examination. A boost to concentration or a distracting noise? A systematic review of surgeon and anaesthetist perspectives of the benefit of intra-operative music. List of editors Surgeon ability to predict physical activity and sedentary time: Comparison of self-reported and measured activity Sensitivity and specificity of surgeons' intra-operative diagnosis of appendicitis. A systematic review and meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1